What We're Reading: Page 98
Industry reads hand-picked by our editors
Oct 31, 2022
-
The Wall Street Journal
Pfizer Squares Off With Merck, Other Drugmakers Over Lucrative Pneumonia Vaccines
-
Bloomberg
Hong Kong Has a Biotech Talent Problem
-
Reuters
China bars GSK’s prostate drug from national drug bulk-buy programme
-
FierceBiotech
Y-mAbs’ rare disease drug roundly rejected by FDA adcomm over weakness of single-arm trial
Oct 28, 2022
-
STAT
Death of patient in closely watched Alzheimer’s trial raises concern about risk for some groups
-
Science
‘Mirror-image’ protein factories could one day make durable drugs the body can’t break down
-
Wired
America’s Adderall Shortage Could Kill People
-
Reuters
China rolls out first inhalable COVID vaccine
Oct 27, 2022
Oct 26, 2022
Oct 25, 2022
-
NPR
Children’s hospitals grapple with a nationwide surge in RSV infections
-
Reuters
AstraZeneca drug fails one main goal in study of chronic immune disease
-
Science
Merck locates frozen batch of undisclosed Ebola vaccine, will donate for testing in Uganda’s outbreak
-
Literary Hub
How Humans Came To Discover the Unseen World of Cells
Oct 24, 2022
-
Reuters
U.S. is talking to companies about drug price negotiations
-
The Wall Street Journal
Deadly Fungi Are Infecting More Americans
-
Bloomberg
Popular Antibiotic Amoxicillin in Short Supply in US
-
FiercePharma
Ex-Genentech staffers sentenced in trade secrets case
Previous
